REGENEREX PHARMA, INC. Operating Lease Right-of-Use Assets
REGENEREX PHARMA, INC. had Operating Lease Right-of-Use Assets of $487.05 thousand as of 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-31
- 2025-12-31: Operating Lease, Right-of-Use Asset $487.05K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $527.24K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $566.35K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $604.26K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $487.05K 10-KT · filed 2026-08-31 |
| 2025-09-30 | $527.24K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $566.35K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $604.26K 10-KT · filed 2026-08-31 |
| 2024-12-31 | $641.08K 10-Q · filed 2025-02-07 |
| 2024-09-30 | $625.68K 10-Q · filed 2024-11-04 |
| 2024-06-30 | $720.45K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $756.34K 10-K · filed 2025-06-30 |
| 2023-12-31 | $834.29K 10-Q · filed 2024-02-05 |
| 2023-09-30 | $903.59K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $940.35K 10-Q · filed 2023-08-14 |